Mannitol Injection, Solution
Product Images NDC 0409-4031

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Mannitol (NDC 0409-4031). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Mannitol 01)

Chemical structure of mannitol showing its molecular arrangement with multiple hydroxyl (OH) groups and carbon (C) atoms bonded to hydrogen (H) atoms.*

FDA Label Image

Logo (Mannitol 02)

FDA Label Image

Principal Display Panel (50 mL Vial Label)

Label of Mannitol 25% Injection, USP 12.5 g/50 mL (250 mg/mL) single-dose fliptop vial for intravenous use. The label includes a warning about contraindication in severe renal impairment and detailed instructions for use. Distributed by Hospira, Inc., with NDC 0409-4031-16. The vial size is 50 mL.*

FDA Label Image

Principal Display Panel (50 mL Vial Tray)

Label for Mannitol Injection, USP 25% strength, containing 12.5 g/50 mL (250 mg/mL) in a 50 mL single-dose fliptop vial. The label specifies intravenous use only and includes the labeler Hospira, Inc. It denotes US prescription status and provides storage instructions and composition details on the side panels.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.